Direkt zum Inhalt
Merck
  • Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.

Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2014-10-30)
V van Drongelen, E M Haisma, J J Out-Luiting, P H Nibbering, A El Ghalbzouri
ZUSAMMENFASSUNG

Atopic dermatitis is an inflammatory skin disease that is characterized by a reduced skin barrier function, reduced filaggrin (FLG) expression as well as increased colonization by Staphylococcus aureus. This study focused on the possible involvement of FLG in epidermal colonization by S. aureus and/or whether it affects the epidermal defence mechanisms, including the expression of antimicrobial peptides (AMPs) and enzymes involved in stratum corneum barrier lipid synthesis. Furthermore, IL-31 has been shown to reduce FLG expression, but its effects on bacterial colonization and on the expression of AMPs and enzymes involved in the barrier lipid synthesis are not known. We established N/TERT-based epidermal models (NEMs), after FLG knockdown (FLG-KD) and/or cultured with IL-31, that were colonized with S. aureus for 24 h. Both FLG-KD and IL-31 supplementation resulted in significantly increased epidermal S. aureus colonization, as well as in an up-regulation of S. aureus-induced IL-8 expression. IL-31, but not FLG-KD, prevented S. aureus-induced up-regulation of mRNA expression for the AMPs human β-defensin 2 and -3 and RNAse7, whereas psoriasin expression remained unchanged. Furthermore, the S. aureus colonization induced changes in mRNA expression of ELOVL4 was not affected by FLG-KD, but was blocked by IL-31. Expression of SCD-1 and Gcase mRNA was reduced by IL-31, but not by FLG-KD. This study shows that NEMs, with FLG-KD and/or cultured in the presence of IL-31, mimic the skin of patients with atopic dermatitis in several aspects, including enhanced bacterial colonization, increased inflammatory and reduced protective responses.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycerin, ACS reagent, ≥99.5%
Sigma-Aldrich
Glycerin, Molecular Biology, ≥99.0%
Sigma-Aldrich
Glycerin, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
N-Hydroxysuccinimid, 98%
Sigma-Aldrich
Calciumchlorid -Lösung, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
Palmitinsäure, ≥99%
Sigma-Aldrich
Hydrocortison, BioReagent, suitable for cell culture
Sigma-Aldrich
Glycerin, ≥99.5%
Sigma-Aldrich
α-Linoleic acid, ≥98%
Sigma-Aldrich
Calciumchlorid, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
Sigma-Aldrich
Glycerin -Lösung, 83.5-89.5% (T)
Sigma-Aldrich
Hydrocortison, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Glycerin, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Hydrocortison, ≥98% (HPLC)
Sigma-Aldrich
Glycerin, BioUltra, Molecular Biology, anhydrous, ≥99.5% (GC)
Supelco
Glycerin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycerin, BioXtra, ≥99% (GC)
Sigma-Aldrich
Linolsäure, liquid, BioReagent, suitable for cell culture
USP
Glycerin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Palmitinsäure, BioXtra, ≥99%
Sigma-Aldrich
Arachidonsäure, >95.0% (GC)
Sigma-Aldrich
Glycerin, FCC, FG
Sigma-Aldrich
Calciumchlorid, powder, 99.99% trace metals basis
Sigma-Aldrich
Glycerin, meets USP testing specifications
Supelco
Palmitinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Calciumchlorid Dihydrat
Sigma-Aldrich
Arachidonsäure, from non-animal source, ≥98.5% (GC)
Supelco
Hydrocortison, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Selensäure, 98%